Heather Jørgensen

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2026
The CD70/CD27 Axis in Tyrosine Kinase Inhibitor-Treated Chronic Phase Chronic Myeloid Leukemia Cells Is Not an Achilles Heel.

|Jan 21, 2024
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease.

Mary T Scott, Wei Liu, Rebecca Mitchell

|Nov 11, 2022
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy.

Eduardo Gómez-Castañeda, Lisa E M Hopcroft, Simon Rogers

|Jun 04, 2021
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival.

Matthew E Massett, Laura Monaghan, Shaun Patterson

|Sep 16, 2020
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence.

Salihanur Darici, Hazem Alkhaldi, Gillian Horne

|Sep 13, 2018
Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal.

Parto Toofan, Caroline Busch, Heather Morrison

Pageof 2

Frequent Collaborators

4 joint publications

Mhairi Copland

2 joint publications

Helen Wheadon

2 joint publications

Xu Huang

2 joint publications

Alison M Michie